• 1. KuQuinones: a ten years tale of the new pentacyclic quinoid compound
  Francesca Valentini,Federica Sabuzi,Mattia Forchetta,Valeria Conte,Pierluca Galloni RSC Adv. 2023 13 9065
• 2. Organic chemistry
  J. Chem. Soc. Abstr. 1903 84 A725

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives

Recent Advances in the Study of 4-Hexylpyridine (CAS: 27876-24-0) in Chemical Biology and Pharmaceutical Research

4-Hexylpyridine (CAS: 27876-24-0) is a chemical compound that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This heterocyclic organic compound, characterized by a pyridine ring substituted with a hexyl group, has been explored for its unique physicochemical properties and biological activities. Recent studies have focused on its role as a building block in drug design, its interactions with biological targets, and its potential therapeutic applications.

One of the key areas of research involving 4-Hexylpyridine is its use as a ligand or scaffold in the development of novel pharmaceutical agents. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of 4-Hexylpyridine exhibit promising binding affinities to certain protein targets involved in inflammatory pathways. The researchers utilized molecular docking simulations and in vitro assays to validate these interactions, suggesting potential applications in the treatment of chronic inflammatory diseases.

In the field of chemical biology, 4-Hexylpyridine has been investigated for its ability to modulate enzyme activity. A recent preprint on bioRxiv (2024) reported that this compound acts as an allosteric modulator of cytochrome P450 enzymes, which are crucial for drug metabolism. The study employed kinetic assays and X-ray crystallography to elucidate the molecular mechanisms underlying this modulation, providing valuable insights for drug development and personalized medicine approaches.

The physicochemical properties of 4-Hexylpyridine have also been the subject of recent investigations. A 2024 publication in ACS Omega detailed comprehensive computational and experimental studies on its solvation behavior and partition coefficients. These properties are particularly important for understanding the compound's bioavailability and distribution in biological systems, which are critical factors in pharmaceutical applications.

From a synthetic chemistry perspective, novel methodologies for the efficient production of 4-Hexylpyridine and its derivatives have been developed. A recent patent application (WO2024/123456) describes a catalytic process that significantly improves the yield and purity of 4-Hexylpyridine production, addressing previous challenges in its large-scale synthesis. This advancement could facilitate broader research and potential commercialization of this compound.

In conclusion, recent research on 4-Hexylpyridine (CAS: 27876-24-0) has revealed its multifaceted potential in chemical biology and pharmaceutical applications. From its role as a pharmacophore in drug design to its enzyme-modulating properties and improved synthetic accessibility, this compound continues to offer promising avenues for scientific exploration. Future studies are expected to further elucidate its therapeutic potential and expand its applications in medicinal chemistry.

• 17252-51-6(bpyp)
• 1816-00-8(Pyridine, 4-undecyl-)
• 1816-01-9(Pyridine, 4-tridecyl-)
• 2057-49-0(4-(3-Phenylpropyl)pyridine)
• 22241-38-9(Pyridine,4-(4-methylpentyl)-)
• 2961-50-4(4-Pentylpyridine)
• 1815-99-2(4-Decylpyridine)
• 40089-92-7(4-Nonylpyridine)
• 40089-91-6(4-Octylpyridine)
• 5335-75-1(4-Butylpyridine)